GSK pharma's Mepolizumab to be used on prescription of experienced Registered Medical Specialists: CDSCO Panel Dr. Divya Colin26 Nov 2022 6:00 PM ISTNew Delhi: Approving for the amendment in warning statement for GSK Pharmaceuticals' Mepolizumab 100 mg, the Subject Expert Committee (SEC) functional...
CDSCO panel approves GSK pharma's protocol amendment proposal for Mepolizumab Powder for Solution for Injection Dr. Divya Colin20 Nov 2022 3:15 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organization (CDSCO) has approved the drug major GSK...
Monoclonal antibody mepolizumab reduces asthma exacerbations among urban youth: Lancet Dr. Kamal Kant Kohli15 Sept 2022 11:30 AM ISTResearchers have found in a National Institutes of Health clinical trial that Monoclonal antibody mepolizumab, reduces asthma exacerbations among...
Stopping mepolizumab after long-term use increases asthma exacerbations, study says Jacinthlyn Sylvia25 Aug 2022 4:00 AM ISTUSA: Patients who quit using mepolizumab experienced more asthma flare-ups and had worse asthma control than those who continued, says an article...
Pros of Switching from omalizumab or mepolizumab to Benralizumab in asthma patients Isra Zaman1 Jun 2022 10:30 AM ISTPatients diagnosed with severe refractory eosinophilic asthma who experience a partial response with omalizumab or mepolizumab could benefit from...
GSK gets CDSCO panel nod to market Mepolizumab for two rare disease indications Dr. Divya Colin8 March 2022 4:11 PM ISTNew Delhi: Pharmaceutical major, GSK has got a go-head from the Subject Expert Committee (SEC) of the Central Drug Standard Control Organization...
Subcutaneous Mepolizumab treatment for chronic rhinosinusitis decreases nasal polyps and obstruction Medical Dialogues Editorial Team3 Feb 2022 9:00 AM ISTA group of researchers led by Claus Bachert conducted a study which showed that regardless of the existence of asthma or aspirin-exacerbated...
FDA approves Nucala as add-on treatment for chronic rhinosinusitis patients with nasal polyps Hina Zahid2 Aug 2021 9:00 AM ISTThe US Food and Drug Administration (FDA) has approved Nucala as a treatment for adults who have chronic rhinosinusitis with nasal polyps. Nucala...
Mepolizumab May Benefits Patients with Chronic Rhinosinusitis With Nasal Polyps MD Bureau16 March 2021 11:15 PM ISTMepolizumab improves symptoms in Chronic Rhinosinusitis with Nasal Polyps (CRSwNP), suggests a study published in THE JOURNAL OF Allergy AND Clinical...
Mepolizumab may reduce size of nasal polyps, need for surgery in chronic rhinosinusitis Dr. Nandita Mohan27 Oct 2020 7:13 PM ISTAccording to a recent presentation at the annual ERS Congress held virtually this year due to COVID-19, a SYNAPSE study revealed that patients with...
FDA Approves First Ever Drug to Treat Hypereosinophilic Syndrome Hina Zahid28 Sept 2020 2:00 PM ISTSILVER SPRING, Md. - The U.S. Food and Drug Administration has approved first ever biologic for hypereosinophilic syndrome (HES).Nucala (mepolizumab)...
